BACKGROUND/AIMS: Patients value health-related quality of life (HRQOL) over survival. It was our aim to study the relation between attainment of widely accepted performance targets and HRQOL in hemodialysis patients. METHODS: This study included baseline data from 715 hemodialysis patients from 29 dialysis centers. Six clinical performance targets, as recommended by the Kidney Disease Outcomes Quality Initiative (KDOQI), were evaluated: single-pool Kt/V (≥1.2), hemoglobin (11-13 g/dl), vascular access (fistula), phosphorus (2.3-4.5 mg/dl), parathyroid hormone (150-300 pg/ml), and blood pressure (predialysis <140/90 and postdialysis <130/ 80 mm Hg). RESULTS: After correction for case-mix and multiple comparisons, no association was found between the 6 KDOQI clinical performance targets and the 14 HRQOL domains, or between the number of performance targets reached and HRQOL. CONCLUSION: Attainment with widely accepted clinical performance targets was not related to the HRQOL of hemodialysis patients. Hence, in clinical guidelines, HRQOL should be adopted as an explicit treatment goal for these individuals.
BACKGROUND/AIMS: Patients value health-related quality of life (HRQOL) over survival. It was our aim to study the relation between attainment of widely accepted performance targets and HRQOL in hemodialysis patients. METHODS: This study included baseline data from 715 hemodialysis patients from 29 dialysis centers. Six clinical performance targets, as recommended by the Kidney Disease Outcomes Quality Initiative (KDOQI), were evaluated: single-pool Kt/V (≥1.2), hemoglobin (11-13 g/dl), vascular access (fistula), phosphorus (2.3-4.5 mg/dl), parathyroid hormone (150-300 pg/ml), and blood pressure (predialysis <140/90 and postdialysis <130/ 80 mm Hg). RESULTS: After correction for case-mix and multiple comparisons, no association was found between the 6 KDOQI clinical performance targets and the 14 HRQOL domains, or between the number of performance targets reached and HRQOL. CONCLUSION: Attainment with widely accepted clinical performance targets was not related to the HRQOL of hemodialysis patients. Hence, in clinical guidelines, HRQOL should be adopted as an explicit treatment goal for these individuals.
Authors: Laura Sola; Nathan W Levin; David W Johnson; Roberto Pecoits-Filho; Harith M Aljubori; Yuqing Chen; Stefaan Claus; Allan Collins; Brett Cullis; John Feehally; Paul N Harden; Mohamed H Hassan; Fuad Ibhais; Kamyar Kalantar-Zadeh; Adeera Levin; Abdulkarim Saleh; Daneil Schneditz; Irma Tchokhonelidze; Rumeyza Turan Kazancioglu; Ahmed Twahir; Robert Walker; Anthony J O Were; Xueqing Yu; Fredric O Finkelstein Journal: Kidney Int Suppl (2011) Date: 2020-02-19
Authors: Alexandra Moura; José Madureira; Pablo Alija; João Carlos Fernandes; José Gerardo Oliveira; Martin Lopez; Madalena Filgueiras; Leonilde Amado; Maria Sameiro-Faria; Vasco Miranda; Alice Santos-Silva; Elísio Costa Journal: Aging Dis Date: 2014-05-25 Impact factor: 6.745
Authors: Claire H den Hoedt; Michiel L Bots; Muriel P C Grooteman; Albert H A Mazairac; E Lars Penne; Neelke C van der Weerd; Piet M Ter Wee; Menso J Nubé; Renée Levesque; Peter J Blankestijn; Marinus A van den Dorpel Journal: PLoS One Date: 2013-04-19 Impact factor: 3.240
Authors: Pasquale Esposito; Francesco Furini; Teresa Rampino; Marilena Gregorini; Lucia Petrucci; Catherine Klersy; Antonio Dal Canton; Elena Dalla Toffola Journal: Clin Kidney J Date: 2016-11-10
Authors: Marc M Saad; Youssef El Douaihy; Christine Boumitri; Chetana Rondla; Elias Moussaly; Magda Daoud; Suzanne E El Sayegh Journal: Int J Nephrol Renovasc Dis Date: 2015-09-03